| scholarly article | Q13442814 |
| P2093 | author name string | Y Nakamura | |
| H Nagawa | |||
| S K Ono-Nita | |||
| J Kitayama | |||
| N Tsuno | |||
| M E Nita | |||
| O Tominaga | |||
| E Sunami | |||
| T Takenoue | |||
| P2860 | cites work | 5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteins | Q28369128 |
| Drug-target interactions: only the first step in the commitment to a programmed cell death? | Q37188769 | ||
| The role of antiapoptotic Bcl-2 family members in endothelial apoptosis elucidated with antisense oligonucleotides | Q38326195 | ||
| Bcl-2 overexpression results in reciprocal downregulation of Bcl-X(L) and sensitizes human testicular germ cell tumours to chemotherapy-induced apoptosis | Q40970064 | ||
| Modulation of apoptosis by endogenous Bcl-xL expression in MKN-45 human gastric cancer cells | Q40990396 | ||
| Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. | Q41132569 | ||
| 30 KDa phosphorylated form of Bcl-2 protein in human colon | Q41190957 | ||
| Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis | Q41335047 | ||
| Antisense oligonucleotides as therapeutics for malignant diseases. | Q41454086 | ||
| Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. | Q41461017 | ||
| Inhibition of Bcl-xL expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuli | Q41684512 | ||
| Role of apoptotic response in cellular resistance to cytotoxic agents | Q41735655 | ||
| Antiapoptosis potential of bcl-2 oncogene by dephosphorylation | Q42277594 | ||
| bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. | Q42505657 | ||
| Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. | Q44486888 | ||
| Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis | Q45859903 | ||
| Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. | Q45997933 | ||
| Gene inhibition using antisense oligodeoxynucleotides | Q46429559 | ||
| Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides | Q72779505 | ||
| Bcl-2 and Bcl-XL can differentially block chemotherapy-induced cell death | Q73555365 | ||
| bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice | Q74165698 | ||
| BCL-2 gene family and the regulation of programmed cell death | Q77303933 | ||
| P433 | issue | 8 | |
| P921 | main subject | colon cancer | Q18555025 |
| cancer cell line | Q23058136 | ||
| P1104 | number of pages | 8 | |
| P304 | page(s) | 825-832 | |
| P577 | publication date | 2000-08-01 | |
| P1433 | published in | Japanese Journal of Cancer Research | Q26842384 |
| P1476 | title | Bcl-X(L) antisense sensitizes human colon cancer cell line to 5-fluorouracil | |
| P478 | volume | 91 |
| Q35416266 | Adenovirus-mediated siRNA targeting Bcl-xL inhibits proliferation, reduces invasion and enhances radiosensitivity of human colorectal cancer cells |
| Q36795425 | Apoptosis and chemo-resistance in colorectal cancer |
| Q36671167 | Bcl-xL antisense oligonucleotides radiosensitise colon cancer cells |
| Q41828839 | Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway |
| Q38361912 | Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents |
| Q35085222 | Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells |
| Q46550944 | Expression of pro-apoptotic Bfk isoforms reduces during malignant transformation in the human gastrointestinal tract |
| Q35841071 | Molecular aspects of esophageal squamous cell carcinoma carcinogenesis |
| Q34564963 | Molecular aspects of hepatic carcinogenesis |
| Q45855025 | Overexpression of hRFI inhibits 5-fluorouracil-induced apoptosis in colorectal cancer cells via activation of NF-kappaB and upregulation of BCL-2 and BCL-XL. |
| Q30971455 | Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family |
| Q43938032 | Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status |
Search more.